Navigation Links
Fentanyl Narcotic Pain Patch under Scrutiny

Fentanyl skin patches (brand name Duragesic) a potent narcotic medication for pain management// is under FDA scrutiny after reports of deaths in patients using the patch were reported. The FDA says it is conducting an investigation into the deaths associated with these patches as it is unclear if the deaths are due to inappropriate use of the patch or factors related to the quality of the product.

Deaths and overdoses have occurred in patients using both the brand name product Duragesic and the generic product fentanyl. FDA officials say that the directions for using the fentanyl skin patch must be followed exactly to prevent death or other serious side effects from overdosing associated with fentanyl. They also say that some patients and doctors may not be fully aware of the dangers of this very strong narcotic painkiller; hence they feel the need to highlight important safety information about the drug which could benefit both patients and doctors . Some of the signs of overdose associated with fentanyl skin patch include shallow breathing; tiredness, extreme sleepiness, or sedation; inability to think, talk, or walk normally; and feeling faint, dizzy, or confused. FDA officials warn that if these signs occur, patients or their caregivers should get medical attention right away.
'"/>




Page: 1

Related medicine news :

1. UN Report Paints Alarming Picture Of Narcotics Scenario In NE
2. Long-Term Narcotics Use for Back Pain May Be Ineffective and Lead to Abuse
3. FDA Approves Birth Control Skin Patch
4. Estrogen Patch is Safer than Pills for Heart
5. Painkilling Patch As Effective As Intravenous Delivery Systems
6. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
7. FDA Warns Against Birth-Control Patch
8. Nicotine Patches help to quit smoking
9. Reliable Help For Smokers From Nicotine Patches and Former Smokers
10. Increased Risk of Clot with Birth-Control Patch
11. Skin Patch Offers Relief to Patients with Parkinsons disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, ... families throughout the Five Boroughs, is launching a charity drive to raise funds that ... the traditions and spirit of marines and Navy FMF Corpsmen. Working closely with the ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... December 07, 2016 , ... The medical profession is well aware that heart ... major study analyzing heart attacks among 138,602 people recorded a 35% higher number of ... would all agree of course–no time of year is a good time for a ...
(Date:12/7/2016)... Norwalk, CT (PRWEB) , ... December 07, 2016 ... ... the Integrated Infertility and Wellness (IFW) Program at Reproductive Medicine Associates of Connecticut ... which now has a team of three acupuncturists to help patients realize their ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), ... a company overview at the BMO Capital Markets Prescriptions for Success ... NY . A live webcast of the presentation ... Ionis website.  The replay will be available within 48 hours and ... ...
(Date:12/7/2016)... (NYSE: LCI ) today announced that the company will ... Conference on December 14, 2016 at 9:20 a.m. (ET) at the ... In addition, the company will host one-on-one meetings with ... Boston Healthcare Conference taking place on December 13, 2016 at the ... , , ...
(Date:12/6/2016)... -- Alopexx Oncology, LLC announced data from a Phase I ... composed of interleukin-2 and a CD20-targeting monoclonal antibody. The ... as Rituxan and maintains the activities of both the ... tumor targeting, engagement of the immune system, and induction ... study (abstract #95954) were presented at the 58 th ...
Breaking Medicine Technology: